Gene therapy for Parkinson's disease symptoms
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a new type of gene therapy for Parkinson's disease. It aims to make blocking cells more responsive, improving movement control and reducing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease by a doctor.
- You are between 40 and 65 years old.
- You have had Parkinson's for at least 5 years.
- Levodopa (a common Parkinson's medication) currently helps your symptoms.
- You have not had brain surgery (like deep brain stimulation) before.
- You are willing to avoid other treatments and vaccines during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests a new gene therapy for Parkinson's disease in people who have a specific genetic change (GBA1 mutation) that may be causing their symptoms. The treatment aims to fix the root cause by delivering a corrected gene to the brain, which might help improve motor symptoms and reduce 'off' time.
This trial tests a new treatment called NouvNeu001 for people with Parkinson's disease. It aims to see if it's safe, feasible, and effective in improving motor symptoms.
This study tests a new stem cell treatment for Parkinson's disease. It aims to see if the treatment is safe and may help improve symptoms when current medications stop working well.
This trial tests a new gene therapy called BBM-P002 for Parkinson's disease. It aims to see if the treatment is safe and tolerable, and may help people with moderate to advanced Parkinson's who have had the condition for at least 5 years.
This trial tests a new gene therapy that may improve movement control in people with Parkinson's disease. It involves a one-time surgical injection into the brain and requires you to be off your usual Parkinson's medications during some assessments.
Hear when a new Gene Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.